Under-Eye Dermal Fillers: Professional Guide for Tear Trough Treatment

Under-eye hollowing, also called tear trough hollowing or infraorbital hollowing, is one of the most requested concerns in non-surgical aesthetic medicine. Patients often describe the area as looking tired, shadowed, hollow, or aged, even when they are well rested.

Dermal filler treatment may be appropriate for selected under-eye patients, but this area requires advanced training, careful diagnosis, conservative planning, and a clear understanding of vascular and periorbital anatomy. Under-eye filler should not be presented as a simple or routine treatment for every patient with dark circles.

This professional guide reviews tear trough anatomy, patient selection, product considerations, treatment planning, risks, aftercare, and sourcing considerations for clinics offering advanced under-eye filler services.

Explore professional dermal filler supplies at Health Supplies Plus.

The Anatomy of Under-Eye Hollows

Effective under-eye treatment begins with accurate diagnosis. What patients call “dark circles” may be caused by several different factors, and dermal filler is only appropriate for some of them.

Common contributors to under-eye concerns include:

• True tear trough hollowing: A depression between the lower eyelid and cheek that creates shadowing.
• Midface volume loss: Reduced cheek support can make the lower eyelid-cheek transition appear more hollow.
• Thin under-eye skin: Thin skin can make underlying vessels, muscle, or bone structure more visible.
• Pigmentation: Brown discoloration may reflect melanin, sun exposure, genetics, or post-inflammatory change.
• Vascular show-through: Bluish or purple tones may reflect visible underlying vessels or thin skin.
• Lower-eyelid fat pads: Puffiness, bags, or herniated fat may not improve with filler and can worsen if treated incorrectly.
• Festoons or malar edema: Fluid-prone swelling in the lower eyelid or cheek area can make filler treatment unsuitable.
• Skin laxity: Loose or crepey under-eye skin may require skincare, resurfacing, energy-based treatment, or surgical consultation rather than filler alone.

A true tear trough hollow may be appropriate for filler in selected patients. Dark circles caused mainly by pigmentation, vascular show-through, puffiness, or laxity usually require a different approach.

How Dermal Fillers May Improve Tear Trough Hollows

Under-eye filler treatment is intended to soften the transition between the lower eyelid and upper cheek in carefully selected patients. The goal is not to “fill dark circles” broadly, but to address volume-related hollowing that creates shadow.

In suitable patients, an appropriate hyaluronic acid filler may help:

• Reduce the appearance of tear trough shadowing
• Improve the lower eyelid-cheek transition
• Support selected volume-related hollowing
• Create a smoother contour in appropriate anatomy
• Improve the appearance of tired-looking under-eyes caused by hollowing

Clinics should avoid promising a brighter, rested, or youthful appearance for every patient. Results depend on anatomy, product selection, swelling tendency, skin quality, treatment history, and practitioner experience.

Choosing the Right Under-Eye Filler

Product selection is especially important in the under-eye area because the skin is thin, the anatomy is complex, and swelling or product visibility can be more noticeable than in many other treatment areas.

Clinics should verify whether a product is appropriate for infraorbital hollowing or under-eye use according to current product documentation. Product names, indications, and availability may vary.

Professional product-selection considerations may include:

• Current product labelling and indication status
• Whether the filler is appropriate for the under-eye region
• Gel softness and flexibility
• Water-attraction profile and swelling tendency
• Risk of visibility through thin skin
• Practitioner familiarity with the product
• Availability of hyaluronidase for HA fillers
• Patient’s prior filler history and swelling history

Some HA fillers are specifically positioned for infraorbital hollow or under-eye treatment where approved. Other structural fillers intended for cheeks, jawline, or deeper support may be unsuitable for the tear trough region.

Clinics should avoid stating that a filler is ideal for all under-eye patients. The correct product depends on patient anatomy, diagnosis, current labelling, and risk profile.

Patient Selection and Consultation

Patient selection is one of the most important parts of under-eye filler treatment. A patient may request filler, but the consultation should determine whether filler is the right solution.

A professional under-eye consultation should include:

• Assessment of hollowing versus pigmentation, puffiness, laxity, or vascular show-through
• Lower eyelid and cheek anatomy
• Midface support and volume distribution
• Skin thickness, elasticity, and texture
• Presence of under-eye bags, fat pads, festoons, or malar edema
• Baseline asymmetry
• Prior filler, surgery, laser, peel, thread, or complication history
• History of swelling, allergies, sinus issues, or fluid retention
• Medical history and medication review
• Pregnancy or breastfeeding considerations
• Discussion of risks, alternatives, limitations, and maintenance
• Informed consent and product documentation

Patients may not be suitable candidates if they have significant under-eye bags, festoons, fluid-prone swelling, severe skin laxity, poor skin elasticity, active infection or inflammation, complex prior filler complications, unrealistic expectations, or contraindications listed in the selected product’s labelling.

Professional Treatment Planning

Under-eye filler treatment should be planned conservatively. Public-facing content should not provide injection-depth instructions, injection-point maps, product amounts, or step-by-step procedural technique. Those details belong in formal product training, current product documentation, and internal clinical protocols.

A high-level professional workflow may include:

• Confirming the patient is an appropriate candidate
• Reviewing current product documentation
• Discussing alternative treatments when filler is not appropriate
• Obtaining informed consent
• Using sterile preparation according to clinic protocol
• Treating conservatively to reduce overcorrection risk
• Documenting product name, lot number, expiration date, and treatment area
• Providing written aftercare and urgent-warning guidance
• Scheduling follow-up assessment when appropriate

Clinics should avoid describing any single device, needle, cannula, or technique as eliminating risk. Risk reduction depends on advanced training, anatomy knowledge, careful patient selection, appropriate product choice, conservative planning, sterile technique, and written complication-management protocols.

Risks, Side Effects, and Patient Management

Under-eye filler treatment can cause temporary side effects and less common serious complications. Because the treatment area is close to the eye and has complex vascular anatomy, patient counselling should be thorough.

Common Temporary Effects

• Swelling
• Bruising
• Redness
• Tenderness
• Pain or discomfort at treatment sites
• Itching
• Temporary asymmetry
• Firmness, bumps, or contour irregularity

Under-Eye Specific Concerns

• Puffiness or edema: Some patients are prone to under-eye swelling, which can be worsened by filler.
• Tyndall effect: A bluish discoloration can occur if HA filler is visible through thin skin or placed too superficially.
• Lumps or ridges: Irregularities may occur due to product choice, swelling, placement, or tissue response.
• Overcorrection: Too much filler can create a puffy or unnatural lower-eyelid appearance.
• Delayed swelling: Some patients may develop swelling weeks or months after treatment.

Less Common but Serious Risks

Less common but serious risks may include infection, delayed inflammatory reaction, nodules, granulomas, filler migration, scarring, hypersensitivity, poor aesthetic outcome, vascular compromise, and visual symptoms.

Accidental injection of dermal filler into a blood vessel is the most serious filler risk and can cause skin necrosis, stroke, blindness, or other serious injury. Under-eye patients should be instructed to contact the clinic urgently if they experience severe pain, skin blanching, unusual discoloration, visual symptoms, worsening swelling, fever, drainage, or signs of infection.

Because many under-eye fillers are HA-based, they may be dissolved with hyaluronidase when clinically appropriate. However, hyaluronidase does not remove the need for careful diagnosis, conservative treatment planning, and emergency protocols.

Longevity and Follow-Up Considerations

Under-eye filler duration varies by product, amount used, anatomy, metabolism, swelling tendency, prior filler history, and individual response. The under-eye area may hold product longer than more mobile facial regions in some patients, but clinics should avoid guaranteeing a fixed timeline.

Follow-up planning should consider:

• Initial swelling and bruising
• Whether the early result reflects filler effect or temporary edema
• Patient satisfaction and symmetry
• Signs of overcorrection or contour irregularity
• Delayed swelling history
• Whether additional product is appropriate
• Whether dissolving should be considered in selected cases

Because overcorrection is difficult to hide in the under-eye area, conservative treatment and appropriate reassessment are important.

Combining Under-Eye Fillers With Other Treatments

Under-eye filler may be part of a broader periorbital rejuvenation plan, but combination treatment should be individualized. Not every patient needs filler, neuromodulator, resurfacing, or energy-based treatment.

Depending on the diagnosis, complementary options may include:

• Neuromodulators: For selected crow’s feet or dynamic lines.
• Skincare: For pigmentation, hydration, barrier support, and texture.
• Chemical peels or resurfacing: For selected pigment or texture concerns.
• Energy-based treatments: For selected laxity, redness, or texture concerns.
• Surgical consultation: For prominent fat pads, significant laxity, eyelid concerns, or festoons.

Timing and sequencing should consider swelling, inflammation, infection risk, healing time, and the ability to assess results clearly.

Aftercare and Patient Education

Aftercare should be provided in writing and tailored to the product, treatment area, and patient. Depending on clinic guidance, patients may be advised to:

• Avoid strenuous exercise for a short period
• Avoid excessive heat, saunas, steam rooms, tanning, or hot yoga for a short period
• Avoid unnecessary pressure, rubbing, or massage unless instructed
• Avoid alcohol for a short period if recommended
• Avoid applying makeup or skincare actives until advised by the clinic
• Use cold compresses gently if advised
• Monitor for unusual pain, colour change, visual symptoms, or worsening swelling
• Contact the clinic promptly with concerning symptoms
• Attend follow-up assessment if recommended

Patients should not stop prescribed anticoagulants, antiplatelet medicines, anti-inflammatory medicines, or other medications unless advised by the appropriate healthcare provider.

Professional Sourcing for Under-Eye Fillers

Authentic sourcing is essential for patient safety and consistent treatment planning. Under-eye treatments require products that are appropriate for the region and supported by current product documentation.

Before purchasing under-eye dermal fillers, clinics should verify:

• Supplier reputation and professional eligibility requirements
• Exact product name and formulation
• Whether the product is appropriate for the under-eye area
• Current product documentation and labelling
• Packaging integrity and tamper evidence
• Lot number and expiration date
• Storage and handling requirements
• Traceability and recall procedures
• Whether prescription, import, or professional-use restrictions apply

View the professional dermal fillers catalog at Health Supplies Plus.

Under-Eye Filler Frequently Asked Questions

Conclusion

Under-eye dermal filler treatment can be useful for carefully selected patients with true tear trough hollowing. However, this is an advanced treatment area that requires accurate diagnosis, conservative planning, appropriate product selection, informed consent, and clear complication-management protocols.

Clinics should avoid treating every dark-circle concern with filler. Pigmentation, vascular show-through, puffiness, fat pads, laxity, and festoons may require skincare, resurfacing, energy-based treatment, medical assessment, or surgical consultation instead.

For clinics offering under-eye filler, responsible practice depends on authentic sourcing, current product documentation, advanced training, patient selection, sterile technique, written aftercare, and prompt management of adverse events.

Licensed medical professionals can view dermal filler supplies at Health Supplies Plus.

This content is intended for professional informational purposes only and does not replace medical advice, diagnosis, treatment, emergency protocols, product-specific training, manufacturer instructions, prescribing information, legal guidance, regulatory guidance, purchasing policies, or applicable clinical protocols. Under-eye filler, tear trough filler, hyaluronic acid dermal fillers, hyaluronidase, and related injectable aesthetic treatments should only be purchased, stored, handled, and administered by qualified professionals in accordance with local laws, product labelling, scope-of-practice rules, storage requirements, sterile technique, and appropriate standards of care.

Doris

About the Author: Doris Dickson is a specialist writer for Health Supplies Plus, focusing on the aesthetic medicine industry. She diligently researches cosmetic treatments and products to provide clear, concise information relevant to licensed medical professionals. Her work supports Health Supplies Plus’s commitment to being a reliable informational resource and trusted supplier for the aesthetic community.

Disclaimer: The content provided in this article is intended for informational purposes only and is directed towards licensed medical professionals. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, nor does it constitute an endorsement of any specific product or technique. Practitioners must rely on their own professional judgment, clinical experience, and knowledge of patient needs, and should always consult the full product prescribing information and relevant clinical guidelines before use. Health Supplies Plus does not provide medical advice.